Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health
Condition(s) studied
Investigational drug(s) / intervention(s)
Probiotic: The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Placebo: The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Study summary
Evaluate the effectiveness and safety of Ligilactobacillus salivarius LS97 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Eligibility
Primary outcome measure(s)
- Change in the composition of fecal microbiota before and after intervention. — Week 0 and Week 8
Analyzed by 16S rRNA sequencing.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Xu fei | Zhengzhou | Henan |
More Wecare Probiotics Co., Ltd. trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06886724 on ClinicalTrials.gov ↗ ← All trials in China